Absci (ABSI) Retained Earnings (2020 - 2026)
Absci (ABSI) reported Retained Earnings of -$654.4 million for Q1 2026, down 3444221.05% on a YoY basis from N/an in Q1 2025, and down 110824.7% sequentially from $591000.0 in Q4 2025.
Absci (ABSI) Retained Earnings (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Retained Earnings data on file, last reported at -$654.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 3444221.05% year-over-year to -$654.4 million; the trailing twelve-month figure through Mar 2026 stood at -$654.4 million (down 3444221.05% YoY), and the FY2025 full-year result was $591000.0, up 100.12% from the prior year.
- Retained Earnings retreated to -$654.4 million in Q1 2026, from $591000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $591000.0 in Q4 2025 to a low of -$654.4 million in Q1 2026.
- A 5-year average of -$153.1 million and a median of -$114000.0 in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 525.42% in 2024 and sank 3444221.05% in 2026, its largest moves.
- Tracing ABSI's Retained Earnings over 5 years: stood at -$120000.0 in 2022, then jumped by 69.17% to -$37000.0 in 2023, then sank by 1377200.0% to -$509.6 million in 2024, then jumped by 100.12% to $591000.0 in 2025, then sank by 110824.7% to -$654.4 million in 2026.
- Business Quant data shows ABSI's Retained Earnings at -$654.4 million in Q1 2026, $591000.0 in Q4 2025, and -$595.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -654.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -654.38 Mn |
| Dec 31, 2025 | 591,000.00 |
| Sep 30, 2025 | -595.22 Mn |
| Jun 30, 2025 | -566.52 Mn |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -509.60 Mn |
| Sep 30, 2024 | 251,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Mar 31, 2024 | -132,000.00 |
| Dec 31, 2023 | -37,000.00 |
| Sep 30, 2023 | -59,000.00 |
| Jun 30, 2023 | -146,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | -120,000.00 |
| Sep 30, 2022 | -276.46 Mn |
| Jun 30, 2022 | -61,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -191.03 Mn |
| Sep 30, 2021 | -165.86 Mn |
| Jun 30, 2021 | -11,000.00 |